Provectus Biopharmaceuticals (PVCT) Change in Accured Expenses (2010 - 2025)
Provectus Biopharmaceuticals (PVCT) reported Change in Accured Expenses of $337,094 for Q4 2025, down 45.4% from $617,160 a year earlier but up 67.8% from the prior quarter.
Provectus Biopharmaceuticals (PVCT) Change in Accured Expenses (2010 - 2025) Analysis & Trends
For FY2025, Provectus Biopharmaceuticals posted Change in Accured Expenses of $986,003, down 7.6% from FY2024.
- Change in Accured Expenses has a five-year compound annual growth rate of -10.8% (FY2020 to FY2025).
- By year, Change in Accured Expenses came in at $1.07 million in FY2024 (+27.6%), $836,426 in FY2023 (+107.9%), $402,390 in FY2022 (-57.9%) and $956,834 in FY2021 (-45.3%).
- Five-year quarterly Change in Accured Expenses spans a low of -$144,118 in Q1 2024 and a high of $617,160 in Q4 2024.
- Year over year, Change in Accured Expenses gained in four of the last six quarters, with growth averaging 66.0%.
- The high point for year-over-year Change in Accured Expenses in five years was Q4 2024 (growth of 237.7%); the low point was Q3 2021 (a decline of 99.6%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $200,929 (Q3 2025), $389,828 (Q2 2025) and $58,152 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,158.11 Bn | 1,126.70 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 636.97 Bn | 556.83 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 501.44 Bn | 474.55 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 357.35 Bn | 311.73 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 301.15 Bn | 265.14 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.27 Bn | 238.95 Bn | 12.86 Bn | - |
| 7 | Amgen | 238.93 Bn | 194.33 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 194.19 Bn | 168.38 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 172.28 Bn | 118.93 Bn | 10.94 Bn | - |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 337,094.00 |
| Sep 30, 2025 | 200,929.00 |
| Jun 30, 2025 | 389,828.00 |
| Mar 31, 2025 | 58,152.00 |
| Dec 31, 2024 | 617,160.00 |
| Sep 30, 2024 | 301,710.00 |
| Jun 30, 2024 | 292,129.00 |
| Mar 31, 2024 | -144,118.00 |
| Dec 31, 2023 | 182,762.00 |
| Sep 30, 2023 | 170,645.00 |
| Jun 30, 2023 | 128,767.00 |
| Mar 31, 2023 | 354,252.00 |
| Dec 31, 2022 | -39,965.00 |
| Sep 30, 2022 | 113,220.00 |
| Jun 30, 2022 | 146,134.00 |
| Mar 31, 2022 | 183,001.00 |
| Dec 31, 2021 | 14,577.00 |
| Sep 30, 2021 | 2,045.00 |
| Jun 30, 2021 | 452,250.00 |
| Mar 31, 2021 | 487,962.00 |
Provectus Biopharmaceuticals Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();